Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03226184
Other study ID # 2167/2013
Secondary ID
Status Recruiting
Phase N/A
First received July 19, 2017
Last updated July 19, 2017
Start date July 1, 2012
Est. completion date October 1, 2017

Study information

Verified date July 2017
Source Medical University of Vienna
Contact Lukas K Kriechbaumer, MD
Phone +43 (0) 5 7255 - 57156
Email lukikriechbaumer@hotmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Background:

Even today, postoperative infection is the commonest complications after surgery although all aseptic precautions are taken and causes significant postoperative morbidity, mortality, prolongs hospital stay, and increases costs. Infections that are related to orthopaedic procedures are considered particularly severe when implantation materials are used which further increases the risk of infection and holds the risk of biofilm formation. This is of particular concern since biofilm-mediated infections are difficult to diagnose and effective treatments are lacking. Therefore, new strategies for implant infection are currently being researched worldwide. In this study the relatively new approach for infection control by using an Er:YAG laser was adapted to an orthopaedic and traumatologic setting. This laser vaporizes all water containing cells in a very effective, precise and predictable manner and shows only a minimal thermal damage.

Methods:

For preliminary testing 42 steel pins and 42 plates were cultivated with cocultures for 2 weeks. The minimally necessary laser energy for biofilm removal was determined. We subsequently compared the effectiveness of biofilm removal with the Er:YAG laser and a cleansing of the metal implants with Octenidine soaked gauze. The temperature rise within the metal during the laser procedure was also measured.

In order to achieve an approximation to a clinical setting we want to compared the same effectiveness of biofilm removal similarly on steel pins directly after explantation from patients treated with external fixators for at least 2 weeks. Sonication and SEM will be used for analysis.

Preliminary Results Laser fluences exceeding 2.8J/cm2 caused a complete extinction of all living cells by a single laser impulse. Temperature rise within the implant is dependent on repetition frequency but overall negligible.

The effectiveness of biofilm removal after cleansing with Octenidine soaked gauze and irradiation with the Er:YAG laser will be evaluated on cultivated and extracted pins.

Conclusions We want to compare the effectiveness of the Er:YAG laser and Octenidine in the removal of biofilms from half-pins. We hypothesize that thee Er:YAG laser offers a secure, complete and non toxic removal of all kinds of pathogens from steel implants without damaging the implant or possible development of resistances. The precise non-contact removal of adjacent tissue could be an advantage over other disinfectants.

Level of Evidence (II-a)

Clinical Relevance:

Having one more arrow in the quiver for disinfection of percutaneous implants or for septic revision surgery when osteosynthesis equipment or arthroplasties are meant to be left in place would be extremely desirable.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date October 1, 2017
Est. primary completion date September 1, 2017
Accepts healthy volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

All patients that are treated with external fixators for at least 2 weeks and patients whose implants have to be removed during septic revision surgery.

Exclusion Criteria:

Study Design


Related Conditions & MeSH terms

  • Orthopedic Devices Associated With Misadventures, Prosthetic and Other Implants, Materials and Accessory Devices

Locations

Country Name City State
Austria University Clinic of Traumatology, Medical University of Vienna Vienna

Sponsors (2)

Lead Sponsor Collaborator
Medical University of Vienna Paracelsus Medical University

Country where clinical trial is conducted

Austria, 

Outcome

Type Measure Description Time frame Safety issue
Primary Completeness of biofilm removal Is the Er:YAG laser able to remova a microbial biofilm from cultivated or infected implants 2 years
Secondary Side effects Are there side effect to be expected from laser Irradiation either for the implant or for the surrounding tissue in a possible clinical setting 2 years